Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-6-12
pubmed:abstractText
Neoadjuvant chemotherapy may modify the yield of involved axillary lymph nodes. The purpose of this study was to identify the clinical significance of the involved nodal ratios in patients with stage II/III breast cancer treated with neoadjuvant chemotherapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1573-7217
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
116
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
153-60
pubmed:meshHeading
pubmed-meshheading:18787948-Adult, pubmed-meshheading:18787948-Aged, pubmed-meshheading:18787948-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18787948-Axilla, pubmed-meshheading:18787948-Breast Neoplasms, pubmed-meshheading:18787948-Chemotherapy, Adjuvant, pubmed-meshheading:18787948-Combined Modality Therapy, pubmed-meshheading:18787948-Disease-Free Survival, pubmed-meshheading:18787948-Female, pubmed-meshheading:18787948-Humans, pubmed-meshheading:18787948-Lymph Node Excision, pubmed-meshheading:18787948-Lymph Nodes, pubmed-meshheading:18787948-Lymphatic Metastasis, pubmed-meshheading:18787948-Mastectomy, pubmed-meshheading:18787948-Middle Aged, pubmed-meshheading:18787948-Neoadjuvant Therapy, pubmed-meshheading:18787948-Neoplasm Staging, pubmed-meshheading:18787948-Prognosis, pubmed-meshheading:18787948-Radiotherapy, Adjuvant
pubmed:year
2009
pubmed:articleTitle
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
pubmed:affiliation
Department of Internal Medicine, Seoul National University College of Medicine, Chongno-Gu, Seoul, Republic of Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II